Tableau Software Inc. (NYSE: DATA) shares made a handy gain in Tuesday’s session after the company announced a partnership with Narrative Science. Ultimately, the collaboration will enable Tableau Server and Tableau Public customers to receive natural language summaries that explain the insights within their data visualizations.
Users will be able to simply download the free Google Chrome extension and immediately start using it to receive intelligent narratives that can be easily embedded and shared. The extension serves as a first step toward more deeply integrating advanced natural language generation (NLG) into Tableau and supports Tableau’s mission to help people see and understand their data.
With the addition of NLG, smart data discovery platforms can automatically generate a written or spoken context-based narrative of findings in the data that accompanies visualization, storyboard and batch reports, to fully inform the user about what is most important and actionable.
The tech research firm Gartner expects that, due to NLG’s potentially beneficial impact on the expansion of analytics to a broader audience, NLG will be a feature of most modern business intelligence and analytics platforms by 2018.
Francois Ajenstat, chief product officer at Tableau, commented:
We’re dedicated to making our customers successful and ensuring our technology is easy to use. Narratives for Tableau aligns with both of these objectives and we are excited about the partnership with Narrative Science to embed Advanced NLG into our platform, further enabling Tableau users to quickly understand what is most interesting and important in their data.
For some background on Narrative Science, the company is the leader in Advanced NLG for the enterprise. Its Quill platform, an intelligent system, analyzes data from disparate sources, understands what is interesting and important to the end user and then automatically generates perfectly written narratives for any intended audience, at unlimited scale.
Shares of Tableau were trading up over 10% at $60.67 on Tuesday, with a consensus analyst price target of $64.03 and a 52-week trading range of $36.60 to $104.92.